John M. Leonard, M.D.

John M. Leonard, M.D.

Lead Independent DirectoratIntellia Therapeutics· In proxies 2021–2025

Pay in FY2025-67% from the year before · Intellia Therapeutics stock -22.9% the same year

John M. Leonard, M.D. was paid $5.1M in FY2025 (Dec), down 67%. Intellia Therapeutics stock fell 22.9% that year.

Pay$100 in the stock at the end of FY20 → $17
Pay is from the Summary Compensation Table of each Intellia Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Iqvia HoldingsPublic company · 3 yr
    • Lead Independent Director2023 – Present · 3 yrNo stock prices for these years
  2. Intellia TherapeuticsPublic company · 5 yr
    • President, Chief Executive Officer2021 – Present · 5 yrStock in role -79%
  3. QuintilesPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?